NL7706173A - Werkwijze voor het bereiden van nieuwe guanidine- derivaten alsmede van farmaceutische preparaten. - Google Patents

Werkwijze voor het bereiden van nieuwe guanidine- derivaten alsmede van farmaceutische preparaten.

Info

Publication number
NL7706173A
NL7706173A NL7706173A NL7706173A NL7706173A NL 7706173 A NL7706173 A NL 7706173A NL 7706173 A NL7706173 A NL 7706173A NL 7706173 A NL7706173 A NL 7706173A NL 7706173 A NL7706173 A NL 7706173A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
guanidine derivatives
preparing new
new guanidine
preparing
Prior art date
Application number
NL7706173A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB23331/76A external-priority patent/GB1530675A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of NL7706173A publication Critical patent/NL7706173A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NL7706173A 1976-06-05 1977-06-03 Werkwijze voor het bereiden van nieuwe guanidine- derivaten alsmede van farmaceutische preparaten. NL7706173A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23331/76A GB1530675A (en) 1976-06-05 1976-06-05 Guanidine derivatives
GB305677 1977-01-26

Publications (1)

Publication Number Publication Date
NL7706173A true NL7706173A (nl) 1977-12-07

Family

ID=26237989

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7706173A NL7706173A (nl) 1976-06-05 1977-06-03 Werkwijze voor het bereiden van nieuwe guanidine- derivaten alsmede van farmaceutische preparaten.

Country Status (15)

Country Link
US (1) US4140793A (OSRAM)
JP (1) JPS52151161A (OSRAM)
AU (1) AU509883B2 (OSRAM)
CA (1) CA1070691A (OSRAM)
CH (1) CH641159A5 (OSRAM)
CY (1) CY1130A (OSRAM)
DE (1) DE2724989A1 (OSRAM)
DK (1) DK248177A (OSRAM)
FR (1) FR2353530A1 (OSRAM)
HK (1) HK57981A (OSRAM)
IE (1) IE45198B1 (OSRAM)
KE (1) KE3170A (OSRAM)
MY (1) MY8200180A (OSRAM)
NL (1) NL7706173A (OSRAM)
SE (1) SE424861B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
GB1588096A (en) * 1978-05-20 1981-04-15 Wyeth & Bros Ltd John Pyrrole derivatives
US4332822A (en) * 1980-02-05 1982-06-01 John Wyeth & Brother Limited Guanidine derivatives
FR2490026A1 (fr) * 1980-09-09 1982-03-12 Thomson Csf Antenne reseau non dispersive et son application a la realisation d'une antenne a balayage electronique
US4563475A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Guanidine derivatives for treating gastrointestinal motility dysfunction
JPH01106831U (OSRAM) * 1988-01-08 1989-07-19
RU2006142552A (ru) * 2004-06-16 2008-07-27 Вайет (Us) Производные амино-5,5-дифенилимидазолона как ингибиторы b-секретазы
PE20060299A1 (es) * 2004-06-16 2006-05-18 Wyeth Corp DIFENILIMIDAZOPIRIMIDINA E -IMIDAZOL AMINAS COMO INHIBIDORES DE ß-SECRETASA
CA2593515A1 (en) * 2005-01-14 2006-07-20 Wyeth Amino-imidazolones for the inhibition of beta-secretase
AU2006211159A1 (en) * 2005-02-01 2006-08-10 Wyeth Amino-pyridines as inhibitors of beta-secretase
JP2008530103A (ja) * 2005-02-14 2008-08-07 ワイス β−セクレターゼ阻害剤としてのアゾリルアシルグアニジン
TW200738683A (en) * 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
WO2007005404A1 (en) * 2005-06-30 2007-01-11 Wyeth AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
TW200730523A (en) * 2005-07-29 2007-08-16 Wyeth Corp Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
CA2623245A1 (en) * 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
BRPI0620025A2 (pt) * 2005-12-19 2011-10-25 Wyeth Corp composto, método para o tratamento de uma doença ou transtorno associado a atividade excessiva de bace, método para modular a atividade de bace, composição farmacêutica e uso do composto
WO2007100536A1 (en) * 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) * 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
MX2009003102A (es) * 2006-09-21 2009-04-01 Wyeth Corp INDOLILALQUILPIRIDIN-2-AMINAS PARA LA INHIBICION DE ß-SECRETASA.
PE20090160A1 (es) * 2007-03-20 2009-02-11 Wyeth Corp COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3189601A (en) * 1964-01-10 1965-06-15 Ciba Geigy Corp N, n-alkylene-imino-lower alkanoamidine compounds

Also Published As

Publication number Publication date
CY1130A (en) 1982-02-19
IE45198B1 (en) 1982-07-14
AU509883B2 (en) 1980-05-29
KE3170A (en) 1981-12-18
SE7706520L (sv) 1978-01-20
JPS613332B2 (OSRAM) 1986-01-31
FR2353530B1 (OSRAM) 1981-07-17
DK248177A (da) 1977-12-06
IE45198L (en) 1977-12-05
CH641159A5 (de) 1984-02-15
CA1070691A (en) 1980-01-29
AU2535677A (en) 1978-11-23
DE2724989A1 (de) 1977-12-15
US4140793A (en) 1979-02-20
FR2353530A1 (fr) 1977-12-30
HK57981A (en) 1981-12-04
SE424861B (sv) 1982-08-16
JPS52151161A (en) 1977-12-15
MY8200180A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
NL7706173A (nl) Werkwijze voor het bereiden van nieuwe guanidine- derivaten alsmede van farmaceutische preparaten.
NL7702954A (nl) Werkwijze voor het bereiden van farmaceutische preparaten.
NL7611274A (nl) Werkwijze voor het bereiden van nieuwe geblok- keerde derivaten van cholecalciferol en dihy- drotachysterol3.
NL7703440A (nl) Werkwijze voor het bereiden van nieuwe amino- chromanolderivaten, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7703898A (nl) Werkwijze voor het bereiden van 2-gesubstitueer- de trans-hexahydropyridoindolen, werkwijze voor het bereiden van farmaceutische preparaten met toepassing daarvan alsmede zo gevormde prepara- ten.
NL7704290A (nl) Werkwijze voor het bereiden van nieuwe adenine- derivaten, alsmede deze verbindingen bevattende farmaceutische preparaten.
NL7800364A (nl) Nieuwe 11b-gesubstitueerde 1,3,5-(10)-trienische steroidederivaten, werkwijze voor het bereiden daarvan en farmaceutische preparaten.
NL7612937A (nl) Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
NL7900444A (nl) Guanidinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
NL7703011A (nl) Werkwijze voor het bereiden van 1-azacarbocy- clische 2-ylideenderivaten van guanidine, werk- wijze voor het bereiden van een farmaceutisch preparaat met toepassing daarvan alsmede zo gevormd preparaat.
NL7612941A (nl) Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
NL7700819A (nl) Werkwijze voor het bereiden van nieuwe chro- manderivaten, alsmede deze verbindingen bevatten- de farmaceutische preparaten.
NL7604780A (nl) Werkwijzen voor het bereiden en toepassen van carbamaten en ureumderivaten.
NL184111C (nl) Werkwijze voor het bereiden van androstenonen en van farmaceutische preparaten welke deze bevatten.
NL7706742A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe cefalosplrinederivaten.
NL7612073A (nl) Werkwijze voor het bereiden van nieuwe penicil- linen, alsmede deze penicillinen bevattende farmaceutische preparaten.
NL7704611A (nl) Difenoxyalkaanderivaten en werkwijze voor het bereiden daarvan.
NL7708084A (nl) Werkwijze voor het bereiden van gesubstitueerde imidazolen en werkwijze voor het bereiden van farmaceutische preparaten.
NL7612942A (nl) Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
NL7612939A (nl) Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
NL7701925A (nl) Werkwijzen voor het bereiden en toepassen van chinolinederivaten.
NL7709477A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe cefalosporine- derivaten.
NL7606346A (nl) Werkwijze voor het bereiden van 4-gesubstitueerde pyrazoolderivaten en werkwijze voor het bereiden van farmaceutische preparaten alsmede de toepas- sing daarvan.
NL7604894A (nl) Werkwijzen voor het bereiden en toepassen van chinazolinederivaten.
NL7609962A (nl) Werkwijze voor het bereiden van 5-oxohexaanzuur en zijn derivaten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed